Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 11,038 | 0 | 2,820 | 0 |
| Gross Profit | N/A | 8,650 | N/A | 2,820 | N/A |
| Operating Expenses | 24,360 | 29,333 | 23,461 | 22,570 | 22,914 |
| Operating Income | -24,360 | -18,295 | -23,461 | -19,750 | -22,914 |
| Other Income | 1,088 | 1,292 | 1,458 | 1,679 | 1,756 |
| Pre-tax Income | -23,272 | -17,003 | -22,003 | -18,071 | -21,158 |
| Income Tax | 0 | 1,103 | N/A | 283 | 0 |
| Net Income Continuous | -23,272 | -18,106 | -22,003 | -18,354 | -21,158 |
| Net Income | $-23,272 | $-18,106 | $-22,003 | $-18,354 | $-21,158 |
| EPS Basic Total Ops | -0.37 | -0.28 | -0.35 | -0.30 | -0.35 |
| EPS Basic Continuous Ops | -0.37 | -0.29 | -0.35 | -0.30 | -0.35 |
| EPS Diluted Total Ops | -0.37 | -0.28 | -0.35 | -0.30 | -0.35 |
| EPS Diluted Continuous Ops | -0.37 | -0.29 | -0.35 | -0.30 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.29 | -0.35 | -0.30 | -0.35 |
| EBITDA(a) | $-24,140 | $-15,773 | $-23,466 | $-20,111 | $-23,519 |